Answers are grounded in this paper and cite their sources.
In vitro and in vivo tests show phytoglycogen-based hydrogels improve wound healing by promoting cell proliferation and reducing inflammation.
Management of chronic diabetic wound is an emerging challenge, and designing a multi-functional hydrogel to promote wound repair is urgent for therapy. We firstly discovered a natural hydrogel dressing from modified phytoglycogen (PG) with cationization and oxidation for the Schiff base cross-linking. In vitro and in vivo studies reveal the hydrogel exhibited the favorable adhesion, self-healing, antibacterial and antioxidant properties, and the optimal CPG2-Gel forms efficient coverage in wound without contamination and infection. In the diabetic wound model, high substitution degree cationic PG hydrogel (CPG2-Gel) expedited the reactive oxygen species (ROS) clearance and immunoregulation, promoting cell proliferation, collagen deposition, and tissue formation to facilitate the wound closure with the healing rate of 1.76-fold compared to commercial dressing. The tumor necrosis factor-α (TNF-α) level was reduced to 87.5%, whereas the vascular endothelial growth factor (VEGF) and transforming growth factor-β (TGF-β) were enhanced up to 1.36 and 2.01 times, respectively. The mitogen-activated protein kinase (MAPK), nuclear factor-κB (NF-κB), and janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathways played crucial roles in mediating the polarization of alternatively activated macrophages (M2 macrophages), thereby facilitating cell proliferation, exerting anti-inflammatory effects, and regulating immune responses. This work can provide a facile and promising strategy for fabricating a multifunctional hydrogel dressing for fast therapy of diabetic wound.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: